Becton Dickinson
About: Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
Employees: 74,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
111% more call options, than puts
Call options by funds: $332M | Put options by funds: $157M
1.35% more ownership
Funds ownership: 88.86% [Q1] → 90.21% (+1.35%) [Q2]
6% less repeat investments, than reductions
Existing positions increased: 548 | Existing positions reduced: 585
6% less funds holding
Funds holding: 1,592 [Q1] → 1,492 (-100) [Q2]
24% less capital invested
Capital invested by funds: $58.5B [Q1] → $44.3B (-$14.2B) [Q2]
33% less first-time investments, than exits
New positions opened: 159 | Existing positions closed: 236
52% less funds holding in top 10
Funds holding in top 10: 25 [Q1] → 12 (-13) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
|
Morgan Stanley
Patrick Wood
|
$197
|
Overweight
Maintained
|
11 Aug 2025 |
|
Wells Fargo
Lawrence Biegelsen
|
$184
|
Equal-Weight
Maintained
|
8 Aug 2025 |
|
Piper Sandler
Jason Bednar
|
$200
|
Neutral
Maintained
|
8 Aug 2025 |
Financial journalist opinion
Based on 8 articles about BDX published over the past 30 days
